{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T14:45:59Z","timestamp":1782225959759,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"crossref","award":["V103C-166"],"award-info":[{"award-number":["V103C-166"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"crossref","award":["V104C-175"],"award-info":[{"award-number":["V104C-175"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"crossref","award":["V104E14-003-MY3-2"],"award-info":[{"award-number":["V104E14-003-MY3-2"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"crossref","award":["V105C-189"],"award-info":[{"award-number":["V105C-189"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Research Foundation of Cardiovascular Medicine","award":["100-01-010"],"award-info":[{"award-number":["100-01-010"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.bbrc.2017.03.030","type":"journal-article","created":{"date-parts":[[2017,3,12]],"date-time":"2017-03-12T09:46:24Z","timestamp":1489311984000},"page":"293-299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Amelioration of serum 8-OHdG level by enzyme replacement therapy in patients with Fabry cardiomyopathy"],"prefix":"10.1016","volume":"486","author":[{"given":"Kuan-Hsuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueh-Ching","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Yuan","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueh","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang-Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Hsiu","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuh-Lih","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dau-Ming","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chung","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2017.03.030_bib1","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1093\/hmg\/3.10.1795","article-title":"Fabry disease: twenty-three mutations including sense and antisense CpG alterations and identification of a deletional hot-spot in the alpha-galactosidase A gene","volume":"3","author":"Eng","year":"1994","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2017.03.030_bib2","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJM196705252762101","article-title":"Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency","volume":"276","author":"Brady","year":"1967","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2017.03.030_bib3","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1172\/JCI114027","article-title":"Fabry disease: six gene rearrangements and an exonic point mutation in the alpha-galactosidase gene","volume":"83","author":"Bernstein","year":"1989","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.bbrc.2017.03.030_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human alpha-galactosidase A\u2013replacement therapy in Fabry's disease","volume":"345","author":"Eng","year":"2001","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2017.03.030_bib5","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.bbadis.2011.11.001","article-title":"Globotriaosylceramide is correlated with oxidative stress and inflammation in Fabry patients treated with enzyme replacement therapy","volume":"1822","author":"Biancini","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2017.03.030_bib6","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCGENETICS.109.862920","article-title":"High incidence of the cardiac variant of Fabry disease revealed by newborn screening in the Taiwan Chinese population","volume":"2","author":"Lin","year":"2009","journal-title":"Circ. Cardiovasc Genet."},{"key":"10.1016\/j.bbrc.2017.03.030_bib7","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.bbalip.2013.11.004","article-title":"Gaucher disease and fabry disease: new markers and insights in pathophysiology for two distinct glycosphingolipidoses","volume":"1841","author":"Ferraz","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2017.03.030_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/504601","article-title":"High incidence of later-onset fabry disease revealed by newborn screening","volume":"79","author":"Spada","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbrc.2017.03.030_bib9","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF01606034","article-title":"Cardiocyte storage and hypertrophy as a sole manifestation of Fabry's disease. Report on a case simulating hypertrophic non-obstructive cardiomyopathy","volume":"417","author":"Elleder","year":"1990","journal-title":"Virchows Arch. A Pathol. Anat."},{"key":"10.1016\/j.bbrc.2017.03.030_bib10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0027-5107(92)90072-A","article-title":"Urinary biomarkers and the rate of DNA damage in carcinogenesis and anticarcinogenesis","volume":"267","author":"Simic","year":"1992","journal-title":"Mutat. Res."},{"key":"10.1016\/j.bbrc.2017.03.030_bib11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0009-8981(03)00191-8","article-title":"Urinary 8-hydroxydeoxyguanosine and its analogs as DNA marker of oxidative stress: development of an ELISA and measurement in both bladder and prostate cancers","volume":"334","author":"Chiou","year":"2003","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbrc.2017.03.030_bib12","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1089\/152308603770380034","article-title":"Regulation of hypertrophic and apoptotic signaling pathways by reactive oxygen species in cardiac myocytes","volume":"5","author":"Sabri","year":"2003","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.bbrc.2017.03.030_bib13","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.cardiores.2006.03.016","article-title":"NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure","volume":"71","author":"Murdoch","year":"2006","journal-title":"Cardiovasc Res."},{"key":"10.1016\/j.bbrc.2017.03.030_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cccn.2003.09.010","article-title":"Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics","volume":"339","author":"Wu","year":"2004","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbrc.2017.03.030_bib15","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.talanta.2013.04.064","article-title":"A\u00a0new and fast methodology to assess oxidative damage in cardiovascular diseases risk development through eVol-MEPS-UHPLC analysis of four urinary biomarkers","volume":"116","author":"Mendes","year":"2013","journal-title":"Talanta"},{"key":"10.1016\/j.bbrc.2017.03.030_bib16","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/eurheartj\/ehs166","article-title":"Left ventricular hypertrophy in Fabry disease: a practical approach to diagnosis","volume":"34","author":"Y Yousef","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbrc.2017.03.030_bib17","article-title":"Lysosomal storage diseases: stem cell-based cell- and gene-therapy","author":"Kim","year":"2014","journal-title":"Cell Transpl."},{"key":"10.1016\/j.bbrc.2017.03.030_bib18","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1056\/NEJM199508033330504","article-title":"An atypical variant of Fabry's disease in men with left ventricular hypertrophy","volume":"333","author":"Nakao","year":"1995","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2017.03.030_bib19","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1086\/339431","article-title":"Alternative splicing in the alpha-galactosidase A gene: increased exon inclusion results in the Fabry cardiac phenotype","volume":"70","author":"Ishii","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbrc.2017.03.030_bib20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1399-0004.2004.00219.x","article-title":"The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy","volume":"65","author":"Whybra","year":"2004","journal-title":"Clin. Genet."},{"issue":"5","key":"10.1016\/j.bbrc.2017.03.030_bib21","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00008469-199610000-00001","article-title":"Free radicals, oxidative damage and degenerative diseases","volume":"5","author":"Giacosa","year":"1996","journal-title":"Eur. J. Cancer Prev."},{"issue":"9","key":"10.1016\/j.bbrc.2017.03.030_bib22","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/carcin\/11.9.1447","article-title":"The role of 8-hydroxyguanine in carcinogenesis","volume":"11","author":"Floyd","year":"1990","journal-title":"Carcinogenesis"},{"issue":"24","key":"10.1016\/j.bbrc.2017.03.030_bib23","first-page":"8697","article-title":"Normalization of elevated hepatic 8-hydroxy-2\u2032-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet","volume":"61","author":"Kato","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2017.03.030_bib24","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/MCA.0b013e328344b615","article-title":"Association of serum 8-hydroxy-2-deoxyguanosine levels with the presence and severity of coronary artery disease","volume":"22","author":"Xiang","year":"2011","journal-title":"Coron. Artery Dis."},{"key":"10.1016\/j.bbrc.2017.03.030_bib25","doi-asserted-by":"crossref","first-page":"809","DOI":"10.2337\/db07-1238","article-title":"PPARGC1A variation associated with DNA damage, diabetes, and cardiovascular diseases: the Boston Puerto Rican Health Study","volume":"57","author":"Lai","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2017.03.030_bib26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/eurjhf\/hfq178","article-title":"Urinary 8-hydroxy-2-deoxyguanosine reflects symptomatic status and severity of systolic dysfunction in patients with chronic heart failure","volume":"13","author":"Kobayashi","year":"2011","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.bbrc.2017.03.030_bib27","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/thx.51.4.348","article-title":"Oxidant\/antioxidant imbalance in smokers and chronic obstructive lung disease","volume":"51","author":"Rahman","year":"1996","journal-title":"Thorax"},{"key":"10.1016\/j.bbrc.2017.03.030_bib28","doi-asserted-by":"crossref","first-page":"H2181","DOI":"10.1152\/ajpheart.00554.2011","article-title":"Oxidative stress and heart failure","volume":"301","author":"Tsutsui","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"Suppl A","key":"10.1016\/j.bbrc.2017.03.030_bib29","doi-asserted-by":"crossref","first-page":"A31","DOI":"10.1253\/circj.CJ-08-0014","article-title":"Oxidative stress and mitochondrial DNA damage in heart failure","volume":"72","author":"Tsutsui","year":"2008","journal-title":"Circ. J."},{"key":"10.1016\/j.bbrc.2017.03.030_bib30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10741-007-9079-1","article-title":"Mitochondrial centrality in heart failure","volume":"13","author":"Marin-Garcia","year":"2008","journal-title":"Heart Fail Rev."},{"key":"10.1016\/j.bbrc.2017.03.030_bib31","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s10495-008-0302-x","article-title":"Role of apoptosis in cardiovascular disease","volume":"14","author":"Lee","year":"2009","journal-title":"Apoptosis"},{"issue":"11","key":"10.1016\/j.bbrc.2017.03.030_bib32","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.humpath.2015.07.017","article-title":"Increased oxidative stress contributes to cardiomyocyte dysfunction and death in patients with Fabry disease cardiomyopathy","volume":"46","author":"Chimenti","year":"2015","journal-title":"Hum. Pathol."},{"issue":"3","key":"10.1016\/j.bbrc.2017.03.030_bib33","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ymgme.2008.06.016","article-title":"Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells","volume":"95","author":"Shen","year":"2008","journal-title":"Mol. Genet. Metab."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X17304874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X17304874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T17:50:58Z","timestamp":1589737858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X17304874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0006291X17304874"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2017.03.030","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amelioration of serum 8-OHdG level by enzyme replacement therapy in patients with Fabry cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2017.03.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}